Proline-induced changes in acetylcholinesterase activity and gene expression in zebrafish brain: Reversal by antipsychotic drugs

Neuroscience

Volumn 250, Issue , 2013, Pages 121-128

  Savio, L E B ^a   Vuaden, F C ^a   Kist, L W ^b   Pereira, T C ^b   Rosemberg, D B ^c,d   Bogo, M R ^b   Bonan, C D ^b,d   Wyse, A T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Universidade Comunitaria Regional de Chapeco   (Brazil)

^d Zebrafish Neuroscience Research Consortium ZNRC   (Brazil)

Author keywords

Acetylcholinesterase; Haloperidol; Hyperprolinemia; Inherited diseases; Proline; Supiride; Zebrafish

Indexed keywords

ACETYLCHOLINESTERASE; ACHE PROTEIN; BRAIN PROTEIN; HALOPERIDOL; NEUROLEPTIC AGENT; PROLINE; SULPIRIDE; UNCLASSIFIED DRUG;

ACHE GENE; ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ACTIN GENE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; EF1ALPHA GENE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HYPERPROLINEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZEBRA FISH;

5,5′-DITHIOBIS-2-NITROBENZOIC ACID; ACETYLCHOLINESTERASE; ACHE; ANALYSIS OF VARIANCE; ANOVA; BUCHE; BUTYRYLCHOLINESTERASE; DA; DIETHYLENE-DINITRILO-TETRAACETIC ACID; DOPAMINE; DTNB; EDTA; EGTA; ETHYLENE GLYCOL BIS(BETAAMINOETHYL ETHER)-N,N,N′,N′-TETRAACETIC ACID; HALOPERIDOL; HPI; HPII; HYPERPROLINEMIA; HYPERPROLINEMIA TYPE I; HYPERPROLINEMIA TYPE II; INHERITED DISEASES; PROLINE; QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RT-QPCR; S.E.M.; SCH; STANDARD ERROR OF MEAN; SUPIRIDE; THIOCHOLINE; ZEBRAFISH;

ACETYLCHOLINESTERASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; FEMALE; GENE EXPRESSION; HALOPERIDOL; MALE; NERVE TISSUE PROTEINS; PARASYMPATHETIC NERVOUS SYSTEM; PROLINE; REAL-TIME POLYMERASE CHAIN REACTION; SULPIRIDE; ZEBRAFISH;

EID: 84881515744     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.004     Document Type: Article

References (57)

1. Barbazuk W.B., Korf I., Kadavi C., Heyen J., Tate S., Wun E., Bedell J.A., Mcpherson J.D., Johnson S.L. The syntenic relationship of the zebrafish and human genomes. Genome Res 2000, 10:1351-1358.
2. Bavaresco C.S., Streck E.L., Netto C.A., Wyse A.T.S. Chronic hyperprolinemia provokes a memory deficit in the Morris water maze task. Metab Brain Dis 2005, 20:73-80.
3. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008, 4:567-576.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:218-254.
5. Clemente D., Porteros A., Weruaga E., Alonso J.R., Arenzana F.J., Aijon J., Arevalo R. Cholinergic elements in the zebrafish central nervous system: histochemical and immunohistochemical analysis. J Comp Neurol 2004, 474:75-107.
6. Cohen S.M., Nadler J.V. Sodium-dependent proline and glutamate uptake by hippocampal synaptosomes during postnatal development. Brain Res Dev Brain Res 1997, 100:230-233.
7. David A., Pancharatna K. Effects of acetaminophen (paracetamol) in the embryonic development of zebrafish, Danio rerio. J Appl Toxicol 2009, 29:597-602.
8. Del Arco A., Mora F. Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat. J Neural Transm 2005, 112:97-109.
9. Del Arco A., Segovia G., Mora F. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity. Psychopharmacology (Berlin) 2008, 201:325-338.
10. Delwing D., Chiarani F., Wannmacher C.M.D., Wajner M., Wyse A.T.S. Effect of hyperprolinemia on acetylcholinesterase and butyrylcholinesterase activities in rat. Amino Acids 2005, 28:305-308.
11. Delwing D., Bavaresco C.S., Monteiro S.C., Matté C., Netto C.A., Wyse A.T.S. Alpha-tocopherol and ascorbic acid prevent memory deficits provoked by chronic hyperprolinemia in rats. Behav Brain Res 2006, 168:185-189.
12. Delwing D., Sanna R.J., Wofchuk S., Wyse A.T.S. Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats. Life Sci 2007, 81:1645-1650.
13. Di Rosa G., Pustorino G., Spano M., Campion D., Calabrò M., Aguennouz M., Caccamo D., Legallic S., Sgro D.L., Bonsignore M., Tortorella G. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. Psychiatr Genet 2008, 18:40-42.
14. Dooley K., Zon L.I. Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 2000, 10:252-256.
15. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
16. Ferreira A.G., Scherer E.B., da Cunha M.J., Machado F.R., Cunha A.A., Graeff J.S., Netto C.A., Wyse A.T. Physical exercise reverts cognitive impairment in rats subjected to experimental hyperprolinemia. Neurochem Res 2011, 36:2306-2315.
17. Flynn M.P., Martin M.C., Moore P.T., Stafford J.A., Fleming G.A., Phang J.M. Type II hyperprolinaemia in a pedigree of Irish travellers (nomads). Arch Dis Child 1989, 64:1699-1707.
18. 1A receptors in HEK293 cells. Eur J Pharmacol 2008, 581:37-46.
19. Ichikawa J., Dai J., O'Laughlin I.A., Fowler W.L., Meltzer H.Y. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 2002, 26:325-339.
20. Jacquet H., Demily C., Houy E., Hecketsweiler B., Bou J., Raux G., Lerond J., Allio G., Haouzir S., Tillaux A., Bellegou C., Fouldrin G., Delamillieure P., Ménard J.F., Dollfus S., D'Amato T., Petit M., Thibaut F., Frébourg T., Campion D. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 2005, 10:479-485.
21. 3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine. Eur J Pharmacol 2001, 418:201-206.
22. Jones D.N.C., Gartlon J.E., Minassian A., Perry W., Geyer M. Developing new drugs for schizophrenia: from animals to the clinic. Animal and translational models for CNS drug discovery volume 1: psychiatric disorders 2008, 199-261. Elsevier, New York. R.A. McArthur, F. Borsini (Eds.).
23. Kari G., Rodeck U., Dicker A.P. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 2007, 82:70-80.
24. Keseler I.M., Collado-Vides J., Gama-Castro S., Ingraham J., Paley S., Paulsen I.T., Peralta-Gil M., Karp P.D. EcoCyc: a comprehensive database resource for Escherichia coli. Nucleic Acid Res 2005, 1:334-337.
25. Kessler A., Costabeber E., Dutra-Filho C.S., Wyse A.T.S., Wajner M., Wannmacher C.M.D. Proline reduces creatine kinase activity in the brain cortex of rats. Neurochem Res 2003, 28:1175-1180.
26. Lele Z., Krone P.H. The zebrafish as a model system in developmental, toxicological and transgenic research. Biotechnol Adv 1996, 14:57-72.
27. Long Y., Li Q., Li J., Cui Z. Molecular analysis, developmental function and heavy metal-induced expression of ABCC5 in zebrafish. Comp Biochem Physiol B Biochem Mol Biol 2011, 158:46-55.
28. Mathur P., Guo S. Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 2010, 40:66-72.
29. Mesulam M.M., Guillozet A., Shaw P., Levey A. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002, 110:627-639.
30. Nadler J.V. Sodium-dependent proline uptake in the rat hippocampal formation: association with ipsilateral-commissural projections of CA3 pyramidal cells. J Neurochem 1987, 49:1155-1160.
31. Nadler J.V., Bray S.D., Evenson D.A. Autoradiographic localization of proline uptake in excitatory hippocampal pathways. Hippocampus 1992, 2:269-278.
32. Nedeljkovic N., Banjac A., Horvat A., Stojiljkovic M., Nikezic G. Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex. Int J Dev Neurosci 2005, 23:45-51.
33. Ninkovic J., Folchert A., Makhankov Y.V., Neuhauss S.F.C., Sillaber I., Straehle U., Bally-Cuif L. Genetic identification of AChE as a positive modulator of addiction to the psychostimulant d-amphetamine in zebrafish. J Neurobiol 2006, 66:463-475.
34. Oresic M., Tang J., Seppanen-Laakso T., Mattila I., Saarni S.E., Saarni S.I., Lönnqvist J., Sysi-Aho M., Hyötyläinen T., Perälä J., Suvisaari J. Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 2011, 3:19.
35. Pan Y., Kaiguo M., Razak Z., Westwood J.T., Gerlai R. Chronic alcohol exposure induced gene expression changes in the zebrafish brain. Behav Brain Res 2011, 216:66-76.
36. Parng C., Seng W.L., Semino C., McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002, 1:41-48.
37. Parng C., Roy N.M., Ton C., Lin Y., McGrath P. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 2007, 55:103-112.
38. Paterlini M., Zakharenko S.S., Lai W.S., Qin J., Zhang H., Mukai J., Westphal K.G., Olivier B., Sulzer D., Pavlidis P., Siegelbaum S.A., Karayiorgou M., Gogos J.A. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 2005, 8:1586-1594.
39. Phang J.M., Hu C.A., Valle D. Disorders of proline and hydroxyproline metabolism. The metabolic and molecular bases of inherited disease 2001, vol. 3:1821-1838. McGraw-Hill, New York.
40. +-ATPase activity in the synaptic plasma membrane from cerebral cortex of rats. Metab Brain Dis 1999, 26:1321-1326.
41. +-ATPase activity from rat hippocampus by proline. Neurochem Res 2001, 26:1321-1326.
42. Rico E.P., Rosemberg D.B., Senger M.R., Arizi Mde B., Bernardi G.F., Dias R.D., Bogo M.R., Bonan C.D. Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 2006, 28:489-496.
43. Rosemberg D.B., da Rocha R.F., Rico E.P., Zanotto-Filho A., Dias R.D., Bogo M.R., Bonan C.D., Moreira J.C., Klamt F., Souza D.O. Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain. Neuroscience 2010, 171:683-692.
44. Salgado H., Santos-Zavaleta A., Gama-Castro S., Millan-Zarate D., Diaz-Peredo E., Sanchez-Solano F., Perez-Rueda E., Bonavides- Martinez C., Collado-Vides J. RegulonDB (version 3.2): transcriptional regulation and operon organization in Escherichia coli K-12. Nucleic Acids Res 2001, 29:72-74.
45. Sarter M., Bruno J.P. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol Aging 2004, 25:1127-1139.
46. Savio L.E., Vuaden F.C., Piato A.L., Bonan C.D., Wyse A.T.S. Behavioral changes induced by long-term proline exposure are reverted by antipsychotics in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:258-263.
47. Savio L.E., Vuaden F.C., Rosemberg D.B., Bogo M.R., Bonan C.D., Wyse A.T. Long-term proline exposure alters nucleotide catabolism and ectonucleotidase gene expression in zebrafish brain. Metab Brain Dis 2012, 27:541-549.
48. Seibt K.J., Oliveira Rda L., Rico E.P., Dias R.D., Bogo M.R., Bonan C.D. Typical and atypical antipsychotics alter acetylcholinesterase activity and ACHE expression in zebrafish (Danio rerio) brain. Comp Biochem Physiol C Toxicol Pharmacol 2009, 150:10-15.
49. Soreq H., Seidman S. Acetylcholinesterase - new roles for an old actor. Nat Rev Neurosci 2001, 2:294-302.
50. Tang R., Dodd A., Lai D., Mcnabb W.C., Love D.R. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin 2007, 39:384-390.
51. 3 receptors. Eur J Pharmacol 2011, 666:43-52.
52. Terry A.V., Gearhart D.A., Warner S., Hohnadel E.J., Middlemore M.L., Zhang G., Bartlett M.G., Mahadik S.P. Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats. Neuroscience 2007, 150:413-424.
53. Ton C., Lin Y., Willett C. Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res A Clin Mol Teratol 2006, 76:553-567.
54. Vorstman J.A., Turetsky B.I., Sijmens-Morcus M.E., de Sain M.G., Dorland B., Sprong M., Rappaport E.F., Beemer F.A., Emanuel B.S., Kahn R.S., van Engeland H., Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 2009, 34(3):739-746.
55. Vuaden F.C., Savio L.E., Piato A.L., Pereira T.C., Vianna M.R., Bogo M.R., Bonan C.D., Wyse A.T. Long-term methionine exposure induces memory impairment on inhibitory avoidance task and alters acetylcholinesterase activity and expression in zebrafish (Danio rerio). Neurochem Res 2012, 37:1545-1553.
56. Westerfield M. The zebrafish book 2007, University of Oregon Press, Eugene. 5th ed.
57. Wyse A.T.S., Netto C.A. Behavioral and neurochemical effects of proline. Metab Brain Dis 2011, 26:159-172.